In Inflammation and regeneration
BACKGROUND : The coronavirus disease 2019 (COVID-19) pandemic is widespread; however, accurate predictors of refractory cases have not yet been established. Circulating extracellular vesicles, involved in many pathological processes, are ideal resources for biomarker exploration.
METHODS : To identify potential serum biomarkers and examine the proteins associated with the pathogenesis of refractory COVID-19, we conducted high-coverage proteomics on serum extracellular vesicles collected from 12 patients with COVID-19 at different disease severity levels and 4 healthy controls. Furthermore, single-cell RNA sequencing of peripheral blood mononuclear cells collected from 10 patients with COVID-19 and 5 healthy controls was performed.
RESULTS : Among the 3046 extracellular vesicle proteins that were identified, expression of MACROH2A1 was significantly elevated in refractory cases compared to non-refractory cases; moreover, its expression was increased according to disease severity. In single-cell RNA sequencing of peripheral blood mononuclear cells, the expression of MACROH2A1 was localized to monocytes and elevated in critical cases. Consistently, single-nucleus RNA sequencing of lung tissues revealed that MACROH2A1 was highly expressed in monocytes and macrophages and was significantly elevated in fatal COVID-19. Moreover, molecular network analysis showed that pathways such as "estrogen signaling pathway," "p160 steroid receptor coactivator (SRC) signaling pathway," and "transcriptional regulation by STAT" were enriched in the transcriptome of monocytes in the peripheral blood mononuclear cells and lungs, and they were also commonly enriched in extracellular vesicle proteomics.
CONCLUSIONS : Our findings highlight that MACROH2A1 in extracellular vesicles is a potential biomarker of refractory COVID-19 and may reflect the pathogenesis of COVID-19 in monocytes.
Kawasaki Takahiro, Takeda Yoshito, Edahiro Ryuya, Shirai Yuya, Nogami-Itoh Mari, Matsuki Takanori, Kida Hiroshi, Enomoto Takatoshi, Hara Reina, Noda Yoshimi, Adachi Yuichi, Niitsu Takayuki, Amiya Saori, Yamaguchi Yuta, Murakami Teruaki, Kato Yasuhiro, Morita Takayoshi, Yoshimura Hanako, Yamamoto Makoto, Nakatsubo Daisuke, Miyake Kotaro, Shiroyama Takayuki, Hirata Haruhiko, Adachi Jun, Okada Yukinori, Kumanogoh Atsushi
2022-Nov-30
COVID-19, Exosome, Liquid biopsy, MACROH2A1, Multi-omics, SARS-CoV-2
